Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Apply
BDTX-4933
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step